Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • beetle_doc
    Member
    • Dec 2007
    • 13

    #1

    strange library results

    I have run 3 sample using TruSeq genomic prep using both gel and non gel based methods. The resulting libraries when run on a bioanalyzer all looked like lane 6 of the attached document. Other libraries from the same order looked fine. The input DNA was of sufficient quantity and looked fine on a gel. I have also seen this pattern with one TruSeq RNA library prep sample. Has anyone else seen this?
    Thanks,
    Mike
    Attached Files
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    My first guess would be that they are the TruSeq Control fragments. These are an optional component of both RNA and DNA prep kits. They have a variety of sizes and sequences. The HiSeq Control Software (HCS)/Real Time Analysis (RTA) software recognizes their sequence and their relative proportions are plotted in a pane of the Sequence Analysis Viewer (SAV).

    I don't use them, so I can't tell you for sure. Under normal circumstances I think they are likely at too low of a concentration to be detectable amongst the background of your sample. But in cases where scant sample is present, they might become alarmingly visible. Could be my imagination, but I think I can see faint peaks of similar sizes in lane 5, for example.

    The BioAnalyzer individually scales each lane by default. If you are viewing your data via the Agilient 2100 Expert Software you can turn this behavior off by clicking on the "Gel" tab and the sub-category "Scaling Mode" to choose "Global Scale". I am guessing that if you do this, then the peaks you see clearly in lane 6 will fade into the background. Which indicates the issue is that there is no (or almost no) sample there.

    --
    Phillip

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-13-2026, 12:22 PM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    51 views
    0 reactions
    Last Post SEQadmin2  
    Working...